News
Filter
-
MRC Technology to manage Diabetes UK’s IP
-
Key US Patents Granted for GPCR-Focused Drug Discovery Platform Arising From Pioneering Research and Translational Expertise at MRC and MRC Technology
-
MRC Technology calls for diagnostic collaboration
-
MRC Technology welcomes launch of Knowledge Quarter
-
MRC Technology and Shandong International Biotechnology Park (China) to cooperate in new drug for Alzheimer’s
-
MRC Technology and Yabao Pharmaceuticals Announce Exclusive Partnership in China to Develop Novel Therapeutics for Parkinson’s Disease
-
Charities pledge to jump start drug development for brain diseases
-
Catherine Kettleborough elected to SLAS Europe Council
-
MRC Technology and Proximagen Collaborate to Develop Novel Therapeutics for Inflammatory and Autoimmune Disease
-
Dr. John Stageman Appointed Chair of the Board for MRC Technology
-
Breakthrough Melanoma Treatment, Keytruda, Developed Using Antibody Humanization Expertise at UK’s MRC Technology
-
MRC Technology Announces Humanization of Anti-Tau Monoclonal Antibody for Alzheimer’s Disease Therapy
